The Geriatric Nutritional Risk Index as a prognostic factor in older adult patients with locally advanced head and neck cancer receiving definitive chemoradiotherapy with tri-weekly cisplatin

被引:2
作者
Fujiwara, Yu [1 ,2 ]
Sato, Yasuyoshi [1 ]
Hayashi, Naomi [1 ]
Fukuda, Naoki [1 ]
Wang, Xiaofei [1 ]
Nakano, Kenji [1 ]
Ohmoto, Akihiro [1 ]
Urasaki, Tetsuya [1 ]
Ono, Makiko [1 ]
Tomomatsu, Junichi [1 ]
Toshiyasu, Takashi [3 ]
Mitani, Hiroki [4 ]
Takahashi, Shunji [1 ]
机构
[1] Japanese Fdn Canc Res, Canc Inst Hosp, Dept Med Oncol, 3-8-31 Ariake,Koto Ku, Tokyo 1358550, Japan
[2] Icahn Sch Med Mt Sinai, Mt Sinai Beth Israel, Dept Med, 281 1st Ave, New York, NY 10003 USA
[3] Japanese Fdn Canc Res, Canc Inst Hosp, Dept Radiat Oncol, Tokyo, Japan
[4] Japanese Fdn Canc Res, Canc Inst Hosp, Dept Head & Neck Oncol, Tokyo, Japan
关键词
Head and neck cancer; Geriatric oncology; Chemoradiotherapy; Cisplatin; Nutrition; Geriatric assessment; IMPACT; SCORE;
D O I
10.1016/j.jgo.2023.101523
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Introduction: Concurrent chemoradiotherapy (CCRT) is a standard treatment for locally advanced head and neck cancer (LAHNC) in the definitive setting. The Geriatric Nutritional Risk Index (GNRI) is a screening tool to predict the risk of morbidity and mortality in the older adult. Nutritional management is key during CCRT but the association between prognosis and initial nutritional status in older adults with LAHNC undergoing CCRT remains unknown.Materials and Methods: Patients >= 65 years old with LAHNC who received definitive CCRT with cisplatin (80 mg/ m2 or 100 mg/m2, every three weeks, three times) between 2012 and 2018 were included. Patients without completion of radiotherapy were excluded. Patients were stratified into two groups based on the GNRI (<= 98 or > 98). Overall survival (OS) and event-free survival (EFS) were analyzed by the Kaplan-Meier method and the log -rank test. The Cox proportional hazards model was adopted to identify prognostic factors. GNRI, sex, T and N categories were prespecified as variables for multivariable analysis.Results: The median age of 111 patients (88 male, 79%) was 69 years (interquartile range: 67-71), among which 23 patients had low GNRI (20 male, 87%) and 88 patients had high GNRI (68 male, 77%). Baseline clinical characteristics were not statistically different between the two groups. OS was significantly worse in the low GNRI group than in the high GNRI group (p = 0.048). There was no statistical difference in EFS between the two groups (p = 0.12). Multivariable analysis revealed that low GNRI (hazard ratio [HR]: 3.17, 95% confidence interval [95%CI]: 1.12-8.96, p = 0.029) and higher N category (HR: 4.37, 95% CI: 1.58-12.06, p = 0.004) were associated with worse OS. For EFS, the higher N category was significantly associated with a worse outcome (HR: 2.54, 95% CI: 1.16-5.59, p = 0.02).Discussion: Poorer nutritional status before initiation of CCRT was associated with worse OS in older adults with LAHNC in the definitive setting. The GNRI is a convenient tool for predicting OS in older adult patients with LAHNC treated with CCRT.
引用
收藏
页数:7
相关论文
共 29 条
  • [1] Geriatric Nutritional Risk Index: a new index for evaluating at-risk elderly medical patients
    Bouillanne, O
    Morineau, G
    Dupont, C
    Coulombel, I
    Vincent, JP
    Nicolis, I
    Benazeth, S
    Cynober, L
    Aussel, C
    [J]. AMERICAN JOURNAL OF CLINICAL NUTRITION, 2005, 82 (04) : 777 - 783
  • [2] Impact of the pretreatment Glasgow prognostic score on treatment tolerance, toxicities, and survival in patients with advanced head and neck cancer undergoing concurrent chemoradiotherapy
    Chang, Pei-Hung
    Yeh, Kun-Yun
    Wang, Cheng-Hsu
    Chen, Eric Yen-Chao
    Yang, Shih-Wei
    Huang, Jen-Seng
    Chou, Wen-Chi
    Hsieh, Jason Chia-Hsun
    [J]. HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK, 2017, 39 (10): : 1990 - 1996
  • [3] Glasgow prognostic score after concurrent chemoradiotherapy is a prognostic factor in advanced head and neck cancer
    Chang, Pei-Hung
    Wang, Cheng-Hsu
    Chen, Eric Yen-Chao
    Yang, Shih-Wei
    Chou, Wen-Chi
    Hsieh, Jason Chia-Hsun
    Kuan, Feng-Che
    Yeh, Kun-Yun
    [J]. CHINESE JOURNAL OF CANCER RESEARCH, 2017, 29 (03) : 172 - 178
  • [4] Prognostic Nutritional Index Predicts Toxicity in Head and Neck Cancer Patients Treated with Definitive Radiotherapy in Association with Chemotherapy
    Fanetti, Giuseppe
    Polesel, Jerry
    Fratta, Elisabetta
    Muraro, Elena
    Lupato, Valentina
    Alfieri, Salvatore
    Gobitti, Carlo
    Minatel, Emilio
    Matrone, Fabio
    Caroli, Angela
    Revelant, Alberto
    Lionello, Marco
    Polentin, Viviana Zammattio
    Ferretti, Andrea
    Guerrieri, Roberto
    Chiovati, Paola
    Bertolin, Andy
    Giacomarra, Vittorio
    De Paoli, Antonino
    Vaccher, Emanuela
    Sartor, Giovanna
    Steffan, Agostino
    Franchin, Giovanni
    [J]. NUTRIENTS, 2021, 13 (04)
  • [5] Comparison of the efficacy and safety of the EXTREME regimen for treating recurrent or metastatic head and neck squamous cell carcinoma in older and younger adult patients
    Fukuda, Naoki
    Yunokawa, Mayu
    Fujiwara, Yu
    Wang, Xiaofei
    Ohmoto, Akihiro
    Hayashi, Naomi
    Urasaki, Tetsuya
    Sato, Yasuyoshi
    Nakano, Kenji
    Ono, Makiko
    Tomomatsu, Junichi
    Mitani, Hiroki
    Takahashi, Shunji
    [J]. CANCER REPORTS, 2021, 4 (02)
  • [6] ARTSCAN III: A Randomized Phase III Study Comparing Chemoradiotherapy With Cisplatin Versus Cetuximab in Patients With Locoregionally Advanced Head and Neck Squamous Cell Cancer
    Gebre-Medhin, Maria
    Brun, Eva
    Engstrom, Per
    Haugen Cange, Hedda
    Hammarstedt-Nordenvall, Lalle
    Reizenstein, Johan
    Nyman, Jan
    Abel, Edvard
    Friesland, Signe
    Sjodin, Helena
    Carlsson, Henrik
    Soderkvist, Karin
    Thomasson, Marcus
    Zackrisson, Bjorn
    Nilsson, Per
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (01) : 38 - +
  • [7] Clinical Impact of Cachexia in Head and Neck Cancer Patients Who Received Chemoradiotherapy
    Hayashi, Naomi
    Sato, Yasuyoshi
    Fujiwara, Yu
    Fukuda, Naoki
    Wang, Xiaofei
    Nakano, Kenji
    Urasaki, Testuya
    Ohnnoto, Akihiro
    Ono, Makiko
    Tomomatsu, Junichi
    Sato, Yukiko
    Mitani, Hiroki
    Toshiyasu, Takashi
    Takahashi, Shunji
    [J]. CANCER MANAGEMENT AND RESEARCH, 2021, 13 : 8377 - 8385
  • [8] Underrepresentation of patients 65 years of age or older in cancer-treatment trials.
    Hutchins, LF
    Unger, JM
    Crowley, JJ
    Coltman, CA
    Albain, KS
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1999, 341 (27) : 2061 - 2067
  • [9] Geriatric nutritional risk index in hospitalized heart failure patients
    Kaneko, Hidehiro
    Suzuki, Shinya
    Goto, Masato
    Yuzawa, Yasufumi
    Arita, Takuto
    Yagi, Naoharu
    Murata, Nobuhiro
    Kato, Yuko
    Kano, Hiroto
    Matsuno, Shunsuke
    Otsuka, Takayuki
    Uejima, Tokuhisa
    Takai, Hideaki
    Oikawa, Yuji
    Kunihara, Takashi
    Nagashima, Kazuyuki
    Kirigaya, Hajime
    Sagara, Koichi
    Sawada, Hitoshi
    Aizawa, Tadanori
    Yajima, Junji
    Yamashita, Takeshi
    [J]. INTERNATIONAL JOURNAL OF CARDIOLOGY, 2015, 181 : 213 - 215
  • [10] Geriatric nutritional risk index as a prognostic factor in patients with diffuse large B cell lymphoma
    Kanemasa, Yusuke
    Shimoyama, Tatsu
    Sasaki, Yuki
    Hishima, Tsunekazu
    Omuro, Yasushi
    [J]. ANNALS OF HEMATOLOGY, 2018, 97 (06) : 999 - 1007